Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Russia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20101
20113
20121
20153
20164
20174
20186
20192
20205
20212
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated9
Unknown status4
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Janssen Research & Development, LLC3
Pfizer3
AstraZeneca2
Protagonist Therapeutics, Inc.2
State Scientific Centre of Coloproctology, Russian Federation2
Takeda2
Amgen1
Applied Molecular Transport1
Astellas Pharma Europe Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases38
Colitis, Ulcerative22
Crohn Disease16
Colitis3
Gastrointestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1
Cardiovascular Diseases1
Clostridium Infections1
Colonic Diseases1

Trials

Showing 51 to 38 of 38. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.